Douglas Wolf, MD, FACG

Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates

Poster(s):

• P4346 - Delayed Response to Ozanimod in Patients with Moderate vs Severe Endoscopic Disease: 4-Year Interim Analysis of the True North Open-Label Extension Study
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET